Revolution Medicines, Inc.
RVMD
$41.88
$1.463.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -213.42M | -194.57M | -156.29M | -133.23M | -116.00M |
| Total Depreciation and Amortization | 3.42M | 3.09M | 2.58M | 2.60M | 2.46M |
| Total Amortization of Deferred Charges | 300.00K | 300.00K | 300.00K | 200.00K | 300.00K |
| Total Other Non-Cash Items | 12.83M | 10.87M | 12.65M | 7.01M | -107.00K |
| Change in Net Operating Assets | 2.44M | 42.02M | 10.34M | -4.74M | -47.21M |
| Cash from Operations | -194.44M | -138.29M | -130.42M | -128.17M | -160.56M |
| Capital Expenditure | -3.27M | -1.22M | -3.52M | -2.40M | -3.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.68M | -391.68M | -17.95M | 110.34M | -244.80M |
| Cash from Investing | -15.95M | -392.90M | -21.47M | 107.94M | -247.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 892.00K | 778.10M | 77.29M | 7.50M | 810.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.00K | 95.71M | -- | -- | -- |
| Cash from Financing | 874.00K | 873.81M | 77.29M | 7.50M | 810.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -209.51M | 342.61M | -74.59M | -12.72M | -407.72M |